Temozolomide

FDA Approved: * March 1, 2010
Pharm Company: * BARR
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Temozolomide Overview

Temozolomide (TMZ; brand names Temodar and Temodal and Temcad) is an oral chemotherapy drug. It is an alkylating agent used as a treatment of some brain cancers; as a second-line treatment for astrocytoma and a first-line treatment for glioblastoma multiforme.[1][2][3] Contents 1 Indications 2 Side-effects 3 Mechanism of action 4 Chemical properties 5 History 6 Research 7 References 8 External links Indications Nitrosourea- and procarba...

Read more Temozolomide Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Temozolomide

Recent Temozolomide Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Temozolomide
  • Capsule: 100mg, 140mg, 180mg, 20mg, 250mg, 5mg
  • Injection: 100mg
  • Powder: 100mg/vial
  • Tablet: 100mg, 140mg, 180mg, 250mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Temozolomide: (112 results)

Showing the first 20, Sorted by National Drug Code
  • 0054-0320 Temozolomide 5 mg Oral Capsule by Roxane Laboratories, Inc.
  • 0054-0321 Temozolomide 20 mg Oral Capsule by Roxane Laboratories, Inc.
  • 0054-0322 Temozolomide 100 mg Oral Capsule by Roxane Laboratories, Inc.
  • 0054-0323 Temozolomide 140 mg Oral Capsule by Roxane Laboratories, Inc.
  • 0054-0324 Temozolomide 180 mg Oral Capsule by Roxane Laboratories, Inc.
  • 0054-0325 Temozolomide 250 mg Oral Capsule by Roxane Laboratories, Inc.
  • 0093-7599 Temozolomide 5 mg Oral Capsule by Teva Pharmaceuticals USA Inc
  • 0093-7600 Temozolomide 20 mg Oral Capsule by Teva Pharmaceuticals USA Inc
  • 0093-7601 Temozolomide 100 mg Oral Capsule by Teva Pharmaceuticals USA Inc
  • 0093-7602 Temozolomide 250 mg Oral Capsule by Teva Pharmaceuticals USA Inc
  • 0093-7638 Temozolomide 140 mg Oral Capsule by Teva Pharmaceuticals USA Inc
  • 0093-7639 Temozolomide 180 mg Oral Capsule by Teva Pharmaceuticals USA Inc
  • 0378-5260 Temozolomide 5 mg Oral Capsule by Mylan Pharmaceuticals Inc.
  • 0378-5261 Temozolomide 20 mg Oral Capsule by Mylan Pharmaceuticals Inc.
  • 0378-5262 Temozolomide 100 mg Oral Capsule by Mylan Pharmaceuticals Inc.
  • 0378-5263 Temozolomide 140 mg Oral Capsule by Mylan Pharmaceuticals Inc.
  • 0378-5264 Temozolomide 180 mg Oral Capsule by Mylan Pharmaceuticals Inc.
  • 0378-5265 Temozolomide 250 mg Oral Capsule by Mylan Pharmaceuticals Inc.
  • 0527-1777 Temozolomide 5 mg Oral Capsule by Lannett Company, Inc.
  • 0527-1778 Temozolomide 20 mg Oral Capsule by Lannett Company, Inc.
  • 92 more results ...

Other drugs which contain Temozolomide or a similar ingredient: (1 result)

Related Temozolomide Topics:

Temozolomide
Please be as detailed as possible...






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 20 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA